Resistance to HIV-1 Infection Conferred by a Compound CCR5Delta32 and CCR5 C20S Heterozygote. Alkhatib B, Jabari M, Bilasy S, Abdul-Rahman H, et al. J Infect Dis 2023 Mar 13:jiad062. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Alkhatib B, Jabari M, Bilasy S, Abdul-Rahman H, et al. Resistance to HIV-1 Infection Conferred by a Compound CCR5Delta32 and CCR5 C20S Heterozygote. J Infect Dis 2023 Mar 13:jiad062. doi: 10.1093.
PMID: 36912158